MedTrace Logo

Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions

NCT00597870 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 304

Last updated 2023-09-14

Study results available
· View outcomes & findings →

Summary

The primary objective of this trial is to determine whether the Talent Thoracic Stent Graft, an investigational device, is a safe and effective method of treating thoracic aortic aneurysms (abnormal ballooning of the vessel wall) and other thoracic lesions (dissections, transections, pseudoaneurysms, penetrating ulcers, etc.). The endovascular method is a substitute for the major operation that is performed to treat the lesions.

Conditions

  • Thoracic Aortic Aneurysms
  • Thoracic Transections
  • Intramural Hematoma
  • Pseudoaneurysm
  • Thoracic Aortic Dissection

Interventions

DEVICE

Endoluminal treament of thoracic lesions

Endoluminal treament of thoracic lesions with a thoracic stent-graft

Sponsors & Collaborators

  • Rodney A. White, M.D.

    lead OTHER

Principal Investigators

  • Rodney A. White, M.D. · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00597870 on ClinicalTrials.gov